Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New robot could improve endometrial cancer surgery

NCT ID NCT07027046

Disease control Sponsor: National Cancer Institute, Naples Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing a new robotic system, called da Vinci SP, for surgery to stage and treat endometrial cancer. The surgery involves removing the uterus, ovaries, and fallopian tubes, and checking nearby lymph nodes. Researchers want to see if this robot is safe and effective for these procedures. About 564 patients will take part in this study across multiple centers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Robotic surgical staging using the da Vinci SP system
What this could lead to
If successful, this could show that the da Vinci SP system is a safe and effective option for endometrial cancer surgery, potentially improving recovery and outcomes.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. Complications from surgery are possible, and the new robotic system may not offer advantages over existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 564 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2025

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women with histologically confirmed endometrial carcinoma at first diagnosis who have planned staging surgery for endometrial cancer to be performed using the robotic approach with the da Vinci SP platform

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Histologically confirmed endometrial carcinoma (including uterine carcinosarcoma) * Performance status (ECOG) 0 - 1 * Patients undergoing staging surgery for endometrial cancer, including but not limited to robotic hysterectomy with bilateral salpingo-oophorectomy (ovarian preservation in selected patients is not an exclusion criterion) and possible sentinel lymph node biopsy/pelvic ± para-aortic lymphadenectomy * Signed informed consent to participate in the study Exclusion Criteria: * Patients scheduled for an additional extra-genital surgical procedure during the staging surgery for endometrial carcinoma * Patients with anesthesiological contraindications to a minimally invasive approach * Synchronous tumor * Recurrence of endometrial carcinoma * Dementia or significantly altered mental status that may impair understanding and the ability to provide informed consent * Any reason that may interfere with regular follow-up, even if limited to the first 30 days post-surgery

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometrial cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometrial cancer endometrial carcinoma endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometrial cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • IEO - Istituto Europeo di Oncologia

    RECRUITING

    Milan, Italy

  • Istituti Fisioterapici Ospitalieri - IFO

    RECRUITING

    Roma, Italy

  • Istituto Nazionale Tumori | "Fondazione Pascale"

    RECRUITING

    Naples, Napoli, 80131, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.